Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany

Publikation: Bidrag til tidsskriftKonferenceartikelFormidling

DOI

  1. Monitoring CD8a+ T Cell Responses to Radiotherapy and CTLA-4 Blockade Using [64Cu]NOTA-CD8a PET Imaging

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Imaging HDACs In Vivo: Cross-Validation of the [11C]Martinostat Radioligand in the Pig Brain

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Microvessel Density But Not Neoangiogenesis Is Associated with (18)F-FDG Uptake in Human Atherosclerotic Carotid Plaques

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Structural brain abnormalities associated with cognitive impairments in bipolar disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. NeuroPharm study: EEG wakefulness regulation as a biomarker in MDD

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Parkinson patients have a presynaptic serotonergic deficit: A dynamic deep brain stimulation PET study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • D L Bailey
  • B J Pichler
  • B Gückel
  • G Antoch
  • H Barthel
  • Z M Bhujwalla
  • S Biskup
  • S Biswal
  • M Bitzer
  • R Boellaard
  • R F Braren
  • C Brendle
  • K Brindle
  • A Chiti
  • C la Fougère
  • R Gillies
  • V Goh
  • M Goyen
  • M Hacker
  • L Heukamp
  • G M Knudsen
  • A M Krackhardt
  • I Law
  • J C Morris
  • K Nikolaou
  • J Nuyts
  • A A Ordonez
  • K Pantel
  • H H Quick
  • K Riklund
  • O Sabri
  • B Sattler
  • E G C Troost
  • M Zaiss
  • L Zender
  • T Beyer
Vis graf over relationer

The 6th annual meeting to address key issues in positron emission tomography (PET)/magnetic resonance imaging (MRI) was held again in Tübingen, Germany, from March 27 to 29, 2017. Over three days of invited plenary lectures, round table discussions and dialogue board deliberations, participants critically assessed the current state of PET/MRI, both clinically and as a research tool, and attempted to chart future directions. The meeting addressed the use of PET/MRI and workflows in oncology, neurosciences, infection, inflammation and chronic pain syndromes, as well as deeper discussions about how best to characterise the tumour microenvironment, optimise the complementary information available from PET and MRI, and how advanced data mining and bioinformatics, as well as information from liquid biomarkers (circulating tumour cells and nucleic acids) and pathology, can be integrated to give a more complete characterisation of disease phenotype. Some issues that have dominated previous meetings, such as the accuracy of MR-based attenuation correction (AC) of the PET scan, were finally put to rest as having been adequately addressed for the majority of clinical situations. Likewise, the ability to standardise PET systems for use in multicentre trials was confirmed, thus removing a perceived barrier to larger clinical imaging trials. The meeting openly questioned whether PET/MRI should, in all cases, be used as a whole-body imaging modality or whether in many circumstances it would best be employed to give an in-depth study of previously identified disease in a single organ or region. The meeting concluded that there is still much work to be done in the integration of data from different fields and in developing a common language for all stakeholders involved. In addition, the participants advocated joint training and education for individuals who engage in routine PET/MRI. It was agreed that PET/MRI can enhance our understanding of normal and disrupted biology, and we are in a position to describe the in vivo nature of disease processes, metabolism, evolution of cancer and the monitoring of response to pharmacological interventions and therapies. As such, PET/MRI is a key to advancing medicine and patient care.

OriginalsprogEngelsk
TidsskriftMolecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging
Vol/bind20
Udgave nummer1
Sider (fra-til)4-20
Antal sider17
DOI
StatusUdgivet - feb. 2018

ID: 56619350